• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOFRADIM PRODUCTION SAS UNKNOWN SOFRADIM MESH; MESH, SURGICAL, POLYMERIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOFRADIM PRODUCTION SAS UNKNOWN SOFRADIM MESH; MESH, SURGICAL, POLYMERIC Back to Search Results
Model Number UNKNOWN SOFRADIM MESH
Device Problems Material Deformation (2976); Adverse Event Without Identified Device or Use Problem (2993); Patient Device Interaction Problem (4001)
Patient Problems Abscess (1690); Adhesion(s) (1695); Purulent Discharge (1812); Fistula (1862); Inflammation (1932); Pain (1994); Perforation (2001); Skin Discoloration (2074); Injury (2348); Impaired Healing (2378); Ascites (2596); Blood Loss (2597); No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of vaginal prolapse.It was reported that after implant, the patient experienced right buttock fluid collection concerning for abscess, right gluteal pain, inflammation, purulent drainage, chronic vaginal bleeding, discoloration, piece of mesh protruding from soft tissues into the rectum, adhesions, vaginal pain, non-healing gluteal abscess related to mesh, rectovaginal fistula and rectal mesh perforation.Post-operative patient treatment included incision and drainage of right gluteal abscess with exam of anus/distal rectum under anesthesia, excision of right buttock soft tissue wound, and mesh removal.
 
Manufacturer Narrative
Correction: h6(removed fdd code c63248) medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Additional information: b5, d6, g4 h6:patient code-(b)(6) (breakdown of tract between rectum <(>&<)> vagina) medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of vaginal prolapse.It was reported that after implant, the patient experienced right buttuck fluid collection concerning for abscess, right gluteal pain, inflammation, purulent drainage, chronic vaginal bleeding, discoloration, piece of mesh protruding from soft tissues into the rectum, adhesions, vaginal pain, non-healing gluteal abscess related to mesh, rectal mesh perforation, tract between rectum and vagina had breakdown and a rectovaginal fistula developed.Post-operative patient treatment included incision and drainage of right gluteal abscess with exam of anus/distal rectum under anesthesia, excision of right buttock soft tissue wound, mesh removal, and transvaginal mesh excision.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN SOFRADIM MESH
Type of Device
MESH, SURGICAL, POLYMERIC
Manufacturer (Section D)
SOFRADIM PRODUCTION SAS
116 avenue du formans
trevoux 01600
FR  01600
MDR Report Key9408696
MDR Text Key168998960
Report Number9615742-2019-03815
Device Sequence Number1
Product Code FTL
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial,Followup,Followup
Report Date 03/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberUNKNOWN SOFRADIM MESH
Device Catalogue NumberUNKNOWN SOFRADIM MESH
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/06/2019
Initial Date FDA Received12/04/2019
Supplement Dates Manufacturer Received01/29/2020
02/19/2020
Supplement Dates FDA Received02/06/2020
03/06/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
UNK SOFRADIM ME(LOT#: UNKNOWN); UNK SOFRADIM ME(LOT#: UNKNOWN)
Patient Outcome(s) Required Intervention;
Patient Age63 YR
-
-